Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Steven R. Alberts, MD
Mayo Clinic
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
177 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mayo Clinic Scottsdale
Scottsdale, Arizona, United States
- Aurora Presbyterian Hospital
Aurora, Colorado, United States
- Boulder Community Hospital
Boulder, Colorado, United States
- Penrose Cancer Center at Penrose Hospital
Colorado Springs, Colorado, United States
- Ccop - Colorado Cancer Research Program
Denver, Colorado, United States
- Porter Adventist Hospital
Denver, Colorado, United States
- Presbyterian - St. Luke'S Medical Center
Denver, Colorado, United States
- Rose Medical Center
Denver, Colorado, United States
- St. Anthony Central Hospital
Denver, Colorado, United States
- St. Joseph Hospital
Denver, Colorado, United States
- Swedish Medical Center
Englewood, Colorado, United States
- St. Mary'S Regional Cancer Center at St. Mary'S Hospital and Medical Center
Grand Junction, Colorado, United States
- North Colorado Medical Center
Greeley, Colorado, United States
- Sky Ridge Medical Center
Lone Tree, Colorado, United States
- Hope Cancer Care Center at Longmont United Hospital
Longmont, Colorado, United States
- Mckee Medical Center
Loveland, Colorado, United States
- St. Mary - Corwin Regional Medical Center
Pueblo, Colorado, United States
- North Suburban Medical Center
Thornton, Colorado, United States
- Exempla Lutheran Medical Center
Wheat Ridge, Colorado, United States
- Saint Francis/mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
Hartford, Connecticut, United States
- Illinois Cancercare - Bloomington
Bloomington, Illinois, United States
- St. Joseph Medical Center
Bloomington, Illinois, United States
- Graham Hospital
Canton, Illinois, United States
- Illinois Cancercare - Canton
Canton, Illinois, United States
- Illinois Cancercare - Carthage
Carthage, Illinois, United States
- Memorial Hospital
Carthage, Illinois, United States
- Eureka Community Hospital
Eureka, Illinois, United States
- Illinois Cancercare - Eureka
Eureka, Illinois, United States
- Galesburg Clinic, Pc
Galesburg, Illinois, United States
- Illinois Cancercare - Galesburg
Galesburg, Illinois, United States
- Illinois Cancercare - Havana
Havana, Illinois, United States
- Mason District Hospital
Havana, Illinois, United States
- Illinois Cancercare - Kewanee Clinic
Kewanee, Illinois, United States
- Illinois Cancercare - Macomb
Macomb, Illinois, United States
- Mcdonough District Hospital
Macomb, Illinois, United States
- Trinity Cancer Center at Trinity Medical Center - 7th Street Campus
Moline, Illinois, United States
- Facility name not stated
Moline, Illinois, United States
- Illinois Cancercare - Monmouth
Monmouth, Illinois, United States
- Osf Holy Family Medical Center
Monmouth, Illinois, United States
- Bromenn Regional Medical Center
Normal, Illinois, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2009
- Primary completion
- 30 Apr 2012
- Completion
- 31 May 2013
- Last update posted
- 19 Apr 2022
- Registered enrollment
- 24
- Registry id
- NCT00867321
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.